1. mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion
    Ying Tang et al, 2014, Life Sciences CrossRef
  2. Toward chelerythrine optimization: Analogues designed by molecular simplification exhibit selective growth inhibition in non-small-cell lung cancer cells
    Rosania Yang et al, 2016, Bioorganic & Medicinal Chemistry CrossRef
  3. Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma
    Xuefeng Zhou et al, 2016, Molecular Cancer Research CrossRef
  4. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition
    Kittipong Sanookpan et al, 2021, Molecules CrossRef
  5. Genetic alterations shaping tumor response to anti-EGFR therapies
    Javier Vaquero et al, 2022, Drug Resistance Updates CrossRef
  6. SHOC2 mediates the drug-resistance of triple-negative breast cancer cells to everolimus
    Wenwen Geng et al, 2023, Cancer Biology & Therapy CrossRef
  7. TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN
    Hua Shen et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  8. Alteration in Mir-21/PTEN Expression Modulates Gefitinib Resistance in Non-Small Cell Lung Cancer
    Hua Shen et al, 2014, PLoS ONE CrossRef
  9. Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
    Abderrahim El Guerrab et al, 2020, Scientific Reports CrossRef
  10. Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
    Claudia Fumarola et al, 2014, Biochemical Pharmacology CrossRef
  11. Co-treatment With Everolimus, an mTOR-Specific Antagonist, or Downregulation of ELK1 Enhances the Sensitivity of Pancreatic Cancer Cells to Genistein
    Tianyu Li et al, 2021, Frontiers in Cell and Developmental Biology CrossRef